Expression of microRNA-454 in TGF-β1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum

Parasites and Vectors

Volumn 7, Issue 1, 2014, Pages

  Zhu, Dandan ^a   He, Xue ^a   Duan, Yinong ^a   Chen, Jinling ^a   Wang, Jianxin ^a,b   Sun, Xiaolei ^a   Qian, Hongyan ^b   Feng, Jinrong ^a   Sun, Wei ^a   Xu, Feifan ^a   Zhang, Lingbo ^a  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Hepatic stellate cell; miR 454; Schistosoma japonicum; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; MICRORNA; MICRORNA 454; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; MIRN454 MICRORNA, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATITIS; HUMAN; HUMAN CELL; LIPID METABOLISM; LIVER FIBROSIS; MALE; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; STELLATE CELL; WESTERN BLOTTING; ANIMAL; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; METABOLISM; PARASITOLOGY; PHYSIOLOGY;

ANIMALS; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; HUMANS; LIVER; MALE; MICE; MICE, INBRED ICR; MICRORNAS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84898748261     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-7-148     Document Type: Article

References (25)

1. Mechanisms of hepatic fibrogenesis. Lee UE, Friedman SL, Best Pract Res Clin Gastroenterol 2011 25 2 195 206 10.1016/j.bpg.2011.02.005 21497738
2. Macrophages: master regulators of inflammation and fibrosis. Wynn TA, Barron L, Semin Liver Dis 2010 30 3 245 257 10.1055/s-0030-1255354 20665377
3. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Popov Y, Schuppan D, Hepatology 2009 50 4 1294 1306 10.1002/hep.23123 19711424
4. Liver fibrosis. Bataller R, Brenner DA, J Clin Invest 2005 115 2 209 218 10.1172/JCI24282 15690074 (Pubitemid 40385459)
5. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka AA, Ebeid FA, Parasit Vectors 2012 5 9 22 10.1186/1756-3305-5-9 22236605
6. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 2 281 297 10.1016/S0092-8674(04)00045-5 14744438 (Pubitemid 38167318)
7. Target mimics modulate miRNAs. Chitwood DH, Timmermans MC, Nat Genet 2007 39 8 935 936 10.1038/ng0807-935 17660806 (Pubitemid 47185166)
8. miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. Wang B, Li W, Guo K, Xiao Y, Wang Y, Fan J, Biochem Biophys Res Commun 2012 421 1 4 8 10.1016/j.bbrc.2012. 03.025 22446332
9. Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Chen C, Wu CQ, Zhang ZQ, Yao DK, Zhu L, Exp Cell Res 2011 317 12 1714 1725 10.1016/j.yexcr.2011.05.001 21586285
10. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. Ji J, Zhang J, Huang G, Qian J, Wang X, Mei S, FEBS Lett 2009 583 4 759 766 10.1016/j.febslet.2009. 01.034 19185571
11. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. He Y, Huang C, Sun X, Long XR, Lv XW, Li J, Cell Signal 2012 24 10 1923 1930 10.1016/j.cellsig.2012.06.003 22735812
12. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. Guo CJ, Pan Q, Li DG, Sun H, Liu BW, J Hepatol 2009 50 4 766 778 10.1016/j.jhep.2008.11.025 19232449
13. The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression. Liu L, Nie J, Chen L, Dong G, Du X, Wu X, Tang Y, Han W, PLoS One 2013 8 2 55532 10.1371/journal.pone.0055532 23393589
14. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Inagaki Y, Okazaki I, Gut 2007 56 2 284 292 10.1136/gut.2005.088690 17303605
15. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Venugopal SK, Jiang J, Kim TH, Li Y, Wang SS, Torok NJ, Wu J, Zern MA, Am J Physiol Gastrointest Liver Physiol 2010 298 1 101 G106 10.1152/ajpgi.00220.2009 19892940
16. MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling. Wei J, Feng L, Li Z, Xu G, Fan X, Biomed Pharmacother 2013 67 5 387 392 10.1016/j.biopha.2013.03.014 23643356
17. TGF-β1 gene silencing for treating liver fibrosis. Cheng K, Yang N, Mahato RI, Mol Pharm 2009 6 3 772 779 10.1021/mp9000469 19388665
18. Beta-Catenin signaling is required for TGF-beta1-induced extracellular matrix production by airway smooth muscle cells. Baarsma HA, Menzen MH, Halayko AJ, Meurs H, Kerstjens HA, Gosens R, Am J Physiol Lung Cell Mol Physiol 2011 301 6 956 L965 10.1152/ajplung.00123.2011 21908588
19. Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-beta/Smad signaling. Chen BL, Peng J, Li QF, Yang M, Wang Y, Chen W, World J Gastroenterol 2013 19 9 1405 1415 10.3748/wjg.v19.i9.1405 23539268
20. Emodin protects rat liver from CCl(4)-induced fibrogenesis via inhibition of hepatic stellate cells activation. Dong MX, Jia Y, Zhang YB, Li CC, Geng YT, Zhou L, Li XY, Liu JC, Niu YC, World J Gastroenterol 2009 15 38 4753 4762 10.3748/wjg.15.4753 19824107
21. Inhibition of transforming growth factor-beta-induced liver fibrosis by a retinoic acid derivative via the suppression of Col 1A2 promoter activity. Yang KL, Chang WT, Hung KC, Li EI, Chuang CC, Biochem Biophys Res Commun 2008 373 2 219 223 10.1016/j.bbrc.2008.05.192 18558083
22. Effects of Smad4 on liver fibrosis and hepatocarcinogenesis in mice treated with CCl4/ethanol. Xu XB, He ZP, Leng XS, Liang ZQ, Peng JR, Zhang HY, Xiao M, Zhang H, Liu CL, Zhang XD, Zhonghua Gan Zang Bing Za Zhi 2010 18 2 119 123 20196951
23. MicroRNA-gene expression network in murine liver during Schistosoma japonicum infection. Cai P, Piao X, Liu S, Hou N, Wang H, Chen Q, PLoS One 2013 8 6 67037 10.1371/journal.pone.0067037 23825609
24. Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy. He X, Sai X, Chen C, Zhang Y, Xu X, Zhang D, Pan W, Parasit Vectors 2013 6 272 279 10.1186/1756-3305-6-272 24330517
25. MicroRNA expression profile in different tissues of BALB/c mice in the early phase of Schistosoma japonicum infection. Han H, Peng J, Hong Y, Zhang M, Han Y, Liu D, Fu Z, Shi Y, Xu J, Tao J, Lin J, Mol Biochem Parasitol 2013 188 1 1 9 10.1016/j.molbiopara.2013.02.001 23415751